Oxidative stress has a critical role in the pathogenesis of vitiligo. However, the specific molecular mechanism involved in oxidative stress-induced melanocyte death is not well characterized. Given the powerful role of microRNAs (miRNAs) in the regulation of cell survival as well as the fact that the generation of miRNAs can be affected by oxidative stress, we hypothesized that miRNAs may participate in vitiligo pathogenesis by modulating the expression of vital genes in melanocytes. In the present study, we initially found that miR-25 was increased in both serum and lesion samples from vitiligo patients, and its serum level was correlated with the activity of vitiligo. Moreover, restoration of miR-25 promoted the H 2 O 2 -induced melanocyte destruction and led to the dysfunction of melanocytes. Further experiments proved that MITF, a master regulator in melanocyte survival and function, accounted for the miR-25-caused damaging impact on melanocytes. Notably, other than the direct role on melanocytes, we observed that miR-25 inhibited the production and secretion of SCF and bFGF from keratinocytes, thus impairing their paracrine protective effect on the survival of melanocytes under oxidative stress. At last, we verified that oxidative stress could induce the overexpression of miR-25 in both melanocytes and keratinocytes possibly by demethylating the promoter region of miR-25. Taken together, our study demonstrates that oxidative stress-induced overexpression of miR-25 in vitiligo has a crucial role in promoting the degeneration of melanocytes by not only suppressing MITF in melanocytes but also impairing the paracrine protective effect of keratinocytes. Therefore, it is worthy to investigate the possibility of miR-25 as a potential drug target for anti-oxidative therapy in vitiligo. Vitiligo is a disfiguring dermatosis with an incidence rate of approximately 0.5-1.0% in the populations worldwide.
1
Characterized by patchy depigmentation of the skin, the disease can affect the patients' self-image, or even cause depression, thus substantially decreasing life quality among vitiligo patients. 2 Although several etiological theories, including genetic predisposition, [3] [4] [5] autoimmunity, 6, 7 melanocytorrhagy 8, 9 and toxic metabolites 10 have been proposed to participate in the pathogenesis of vitiligo, the exact mechanism of melanocyte degeneration in depigmented lesions still remains unclear.
The generation of oxidative stress has long been demonstrated to have a crucial role in the onset and progression of vitiligo. 11, 12 Owing to the pro-oxidant state generated during melanin synthesis, melanocytes are particularly vulnerable to oxidative stress. 13 In vitiligo, accumulation of toxic intermediates such as 6-and 7-BH4 and catecholamine, 14, 15 concomitant with reduced levels and activity of catalase and several other antioxidant enzymes [16] [17] [18] have been demonstrated in patients' epidermis. Because of these intracellular metabolic disorder and compromised intrinsic antioxidant defenses, hydrogen peroxide (H 2 O 2 ) and other reactive oxygen species (ROS) accumulate in melanocytes, 19 which causes DNA damage and the peroxidation of lipid and protein, [20] [21] [22] [23] [24] thus disrupting the homeostasis of melanocytes. However, the specific molecular mechanism involved in oxidative stress-induced melanocyte death in vitiligo is not fully clarified, which impedes the discovery of novel drug target for the antioxidant therapy in vitiligo.
MicroRNAs (miRNAs) are a class of noncoding RNAs that suppress gene expression by targeting messenger RNAs for translational repression or, less frequently, degradation. 25, 26 It is known that miRNAs can regulate the growth, differentiation and even death of cells, and the aberrant expression of miRNAs has been found to be involved in the pathogenesis of many diseases. 27 Recently, several studies have found that the expression profile of miRNAs could be regulated by oxidative stress and mediate the pathogenic effect of ROS in some diseases and animal models, which deepens the understanding of redox biology and implicates new therapeutic strategies for oxidative stress-related diseases. [28] [29] [30] Given this crosstalk between redox signaling and miRNAs, we hypothesized that enhanced oxidative stress in vitiligo could induce the aberrant expression of miRNAs, which promotes the degeneration of melanocytes.
To test our hypothesis, a microarray analysis was initially conducted to identify alterations in the miRNAome of vitiligo patients. We discovered that miR-25, one of the most highly elevated miRNAs in vitiligo serum, had a significant correlation with the disease activity and also increased in vitiligo lesion. Subsequent experiments revealed the regulatory effect of miR-25 on the destruction of melanocytes under oxidative stress and the dysfunction of melanocytes, which implicated an important role of miR-25 in the pathogenesis of vitiligo. Meanwhile, the production of miR-25 and the mechanism involved were also investigated in the present study.
Results
Characteristic alterations in the vitiligo miRNAome. In view of the possibility to use serum miRNAs as disease biomarkers, 31 we performed a miRNA microarray study using serum samples from vitiligo patients (n = 50) and healthy controls (n = 50). The assay identified 48 aberrantly expressed miRNAs (4twofold changes, Po0.01), among which 24 miRNAs (e.g., let-7b) were upregulated, whereas another 24 (e.g., miR-1914) were downregulated (Supplementary Table S1 ). We examined the five highest increased miRNAs (let-7b, miR-16, miR-451, miR-25 and miR-15b) in serum samples from vitiligo patients (n = 80) and healthy controls (n = 80) using real-time quantitative reverse transcription-PCR (qRT-PCR). Consistent with the microarray data, all the five miRNAs are significantly (Po0.001) upregulated in vitiligo (Figure 1a) .
Among the five highest increased miRNAs, only miR-25 showed higher level in the serum samples from patients in active stage (n = 40) than those in stable stage (n = 40, Po0.01), while the other four miRNAs showed no difference ( Figure 1b and Supplementary Figure S1 ). We then tested miR-25 level in vitiligo lesion (n = 6) and healthy controls (n = 4). In accordance with its serum level, miR-25 was significantly (Po0.05) elevated in vitiligo lesion (Figure 1c) .
To clarify the location of increased miR-25 in vitiligo lesion, we collected lesional and perilesional skin from vitiligo patients as well as normal skin from healthy individuals, and detected miR-25 by fluorescence in situ hybridization (FISH). As a result, miR-25 is expressed primarily in melanocytes (marked by Melan-A) at the basal layer in healthy epidermis, while the whole epidermis layer of lesional and perilesional skin, most of which are obviously keratinocytes, exhibited much enhanced miR-25 expression. Notably, melanocytes in perilesional skin showed intensely upregulated expression of miR-25 possibly because of some etiological factors like oxidative stress that already existed at the edge of vitiligo lesion (Figure 1d ). MiR-25 promotes the destruction of melanocytes under oxidative stress. To investigate whether increased miR-25 is responsible for melanocyte loss in vitiligo, normal human melanocytes were transfected with miR-25 mimics, miR-25 inhibitor and negative control and examined by annexin V-FITC/PI staining. However, there was no significant distinction among their apoptosis rates (Figures 2a and b) . As oxidative stress is a driven factor for melanocyte loss in vitiligo, we treated those cells with H 2 O 2 (a main form of oxidative stress in vitiligo) and found that the percentage of apoptotic cells was decreased with miR-25 knockdown (28.7 versus 41%), whereas overexpressed miR-25 elevated apoptosis level (65 versus 41%) (Figures 2c and d) . We further found that overexpressed miR-25 reduced the level of anti-apoptotic B-cell lymphoma 2 (Bcl-2) but upregulated some pro-apoptotic proteins, including B-cell lymphoma 2-associated X protein (Bax), the active cleavages of caspase-3 and caspase-9, whereas anti-miR-25 treatment presented with the opposite effect (Figure 2e ). These results indicated that miR-25 could facilitate melanocyte apoptosis under oxidative stress.
Moreover, EdU cell proliferation assay was adopted in our study, and the results showed that the EdU incorporation rate (percentage of cells that undergo cell division) was reduced (Po0.01) in the cells overexpressing miR-25, whereas antimiR-25 treatment increased the number of EdU-positive cells (Po0.05) (Figures 2f and g ).
MiR-25 leads to the dysfunction of melanocytes. The melanin synthesis in melanocytes has been reported to be impaired in vitiligo. 12 In our study, we found that in melanocytes, overexpressed miR-25 inhibited the activity of (Figure 2i ). Along with TYR, tyrosinase-related protein 1 (TYRP1) and tyrosinase-related protein 2 (TYRP2) are also crucial genes in melanin biosynthesis. Using western blotting, we observed the reduction of TYR, TYRP1 and TYRP2 protein level in melanocytes transfected with miR-25 mimics (Figure 2j ). These results indicated that miR-25 suppresses the expression of TYR, TYRP1 and TYRP2, and decreases the activity of tyrosinase, thereby inhibiting melanin biosynthesis.
We further investigated whether miR-25 affected the distribution of melanosomes by detecting gp100 (a marker for melanosomes). As shown in Supplementary Figure S2 , melanosomes were mainly located in the periphery and the dendrites of melanocytes, whereas in cells transfected with miR-25 mimics, we observed a perinuclear aggregation of melanosomes.
MITF are required for miR-25-induced destruction and dysfunction of melanocytes. Three bioinformatics tools including miRanda, PICTAR5 and Targetscan were used to screen the potential targets of miR-25 that may explain its function in melanocytes (Supplementary Figure S3) , and microphthalmia-associated transcription factor (MITF) was selected out for its key role in melanocyte survival and function. We tested MITF level in melanocytes transfected with miR-25 mimics and found that overexpressed miR-25 reduced the expression of MITF at protein level but not at mRNA level (Figure 3a and Supplementary Figure S4a) .
We performed luciferase reporter assays to verify whether miR-25 repressed MITF expression by targeting the predicted sequences in the 3′ untranslated regions (3′UTR) of MITF mRNA. To this end, part of the 3′UTR (1000 nucleotides) with a putative binding site for miR-25 in the middle was inserted into the reporter plasmids and named MITF WT. Furthermore, we mutated four nucleotides within the seed-matching sequences in plasmids named MITF MUT (Figure 3b ). All the reporter plasmids were co-transfected into melanocytes with miR-25 mimics or negative control, and luciferase activity was analyzed 48 h after transfection. In the cells transfected with MITF WT, miR-25 reduced the luciferase activity (Po0.01). However, miR-25 mimics failed to influence the reporter activity of MITF MUT (Figure 3c ). These results indicated that miR-25 directly regulates MITF expression by binding to the predicted target sites in the 3′UTR of its mRNAs.
The inhibition of miR-25 on MITF expression encouraged us to investigate whether the decreased MITF was required for the effect of miR-25 in melanocytes. To test this, melanocytes overexpressing miR-25 were co-transfected with 3′UTR-deleted MITF plasmids or control plasmids (transfection efficiency shown in Supplementary Figure S5) , and flow cytometry was used to evaluate cell apoptosis following H 2 O 2 treatment. The re-introduction of MITF decreased the percentage of apoptotic cells (Po0.05) (Figures 3d and e) , and did invert the downregulation of anti-apoptotic BCL2 and the upregulation of pro-apoptotic Bax, cleaved caspase 3 and caspase 9 induced by miR-25 in melanocytes (Figure 3f ).
According to previous cytometry analysis, the overexpression of miR-25 alone does not affect melanocyte apoptosis (Figures 2a and b) , thus we speculated that its suppression on MITF promoted ROS-induced melanocyte apoptosis by inhibiting the antioxidant response. As a transcriptional target for MITF, 32 apurinic/apyrimidinic endonuclease (APE1) can promote intracellular antioxidant defenses by enhancing the DNA-binding activities of stress-inducible transcription factors, including p53, 33 hypoxia-inducible factor-1 (HIF-1), 34 activator protein-1 (AP-1) 35 and antioxidant factors like nuclear factorerythroid-related factor 2 (NRF2). 36 Besides, using siRNA to deplete APE1 could promote the apoptosis of cells under oxidative stress. 37 On the basis of these findings, we conducted western blotting analysis and found that miR-25 simultaneously downregulated the expression of both MITF and APE1 with or without the stimulation of H 2 O 2 treatment (Figure 3g and Supplementary Figure S6 ). We then found that the transfection of APE1 plasmids into melanoctyes overexpressing miR-25 (transfection efficiency shown in Supplementary Figure S7 ) significantly reduced the miR-25-promoted apoptosis rate of melanocytes under oxidative stress (Po0.05) (Figures 3h and i) . Moreover, we detected the mRNA level of heme oxygenase 1 (HO-1), superoxide dismutase 1 (SOD1), catalase (CAT), glutathione peroxidase 1 (GPX1) and NAD(P)H dehydrogenase, quinone 1 (NQO1), five antioxidant genes downstream of NRF2, 38 in melanocytes transfected by miR-25 mimics, miR-25 inhibitor or negative control. The results showed that the mRNA levels of HO-1 and GPX1 were suppressed by miR-25 in melanocytes with or without the stimulation of H 2 O 2 (Supplementary Figure S8) . Taken together, these findings suggested that miR-25 could suppress the antioxidant ability of melanocytes through inhibiting the MITF-APE1 pathway, thus making melanocytes more susceptible to oxidative stress-induced apoptosis.
We went on to investigate whether miR-25 regulated melanocyte proliferation and function through its inhibition on MITF. The re-introduction of MITF promoted the proliferation of melanocytes transfected with miR-25 mimics (Figures 3j and k), and successfully upregulated the activity of tyrosinase and the melanin content in melanocytes compared with control (Figures 3l and m) . Further western blot assay showed the restoring expression of TYR, TYRP1 and TYRP2 after re-introduction of MITF in melanocytes overexpressing miR-25 ( Figure 3n ). In addition, transfection with MITF plasmids in melanocytes overexpressing miR-25 facilitated the re-location of melanosomes in the periphery (Supplementary Figure S2 ).
MiR-25 inhibits the production and secretion of growth factors in keratinocytes. Studies have found that keratinocytes regulate the proliferation and survival of melanocytes through paracrine mechanism. To investigate the role of keratinocytes overexpressing miR-25 in vitiligo, we treated normal human keratinocytes with miR-25 mimics and tested both the expression and the secretion level of some cytokines and growth factors that have been reported to relate with vitiligo development. 39, 40 Decreased level of of stem cell factor (SCF) and basic fibroblast growth factor (bFGF) were observed in keratinocytes treated with miR-25 mimics. However, the level of endothelin-1 (ET-1), CXCL9 or CXCL10 seemed to be independent on miR-25 in keratinocytes (Figures 4a and b) . We then performed luciferase reporter assays to verify whether miR-25 represses the expression of the two genes by targeting the predicted sequences in their 3′UTR. Reporter plasmids named SCF WT, SCF MUT, bFGF WT and bFGF MUT were constructed in the same way as described before (Figures 4c and e) , and co-transfected with miR-25 mimics or negative control into normal human keratinocytes. It turned out that miR-25 reduced the luciferase activity in cells transfected with SCF WT or bFGF WT (Po0.01), but did not influence the reporter activity of SCF MUT and bFGF MUT (Figures 4d and f) . Therefore, miR-25 suppresses the level of SCF and bFGF by binding to the predicted target sites in the 3′UTR of their mRNAs.
We further treated melanocytes with serum-free media supplemented by culture medium derived from keratinocytes to investigate whether miR-25 influenced the paracrine regulation of keratinocytes on melanocytes. We found that culture medium from miR-25-overexpressing keratinocytes failed to protect melanocytes from H 2 O 2 -induced apoptosis, whereas in the control group, the protective effect was obvious (Figures 4g and h ). Collectively, these results suggested that miR-25 may interfere with the production and the secretion of SCF or bFGF from keratinocytes, thus facilitating melanocyte loss under oxidative stress.
Oxidative stress induces the overexpression of miR-25 in melanocytes and keratinocytes by promoting DNA demethylation. As oxidative stress has been demonstrated to affect miRNA expression, we speculated that the increased miR-25 in both melanocytes and keratinocytes that we observed in previous FISH analysis might result from enhanced oxidative stress in vitiligo. Our qRT-PCR analysis showed that miR-25 was increased in both melanocytes (Po0.01) and keratinocytes (Po0.05) following H 2 O 2 stimulation (Figures 5a and b) . Previous studies have reported that oxidative stress can regulate gene expression by promoting DNA demethylation. 41 We thus adopted the DNA demethylating agent 5-aza-2′-deoxycytidine (5-aza-dC) to test whether such an epigenetic regulation was involved in miR-25 expression. 5-Aza-dC upregulated the level of miR-25 (Po0.05) (Figures 5a and b) , and the maximum increase occurred when the cells were treated with H 2 O 2 and 5-aza-dC simultaneously (Po0.01 for melanocytes and Po0.05 for keratinocytes).
We went on to investigate whether H 2 O 2 demethylated the promoter region of miR-25. Genomic DNA was extracted from melanocytes and keratinocytes with or without H 2 O 2 treatment and subjected to bisulfite sequencing analysis. The distal, central and proximal DNA fragments of the promoter sequences of miR-25 were separated and labeled as miR-25-1, miR-25-2 and miR-25-3 ( Figure 5c ), with 46, 37 and 41 CpG sites involved, respectively (Supplementary Figure S9) . The methylation levels varied at different CpG sites (Figures 5d and e) . For melanocytes, the highest methylation level (50%) occurred at the sixteenth CpG site of miR-25-1 (Figure 5f ), whereas in keratinocytes the highest methylation level (43%) occurred at the twenty-second to twenty-fifth CpG sites of miR-25-2 (Figure 5g ). After H 2 O 2 stimulation, the methylation level of multiple CpG sites in miR-25-1 and miR-25-2 was reduced in both melanocytes and keratinocytes, though there was no change in miR-25-3 (Figures 5f and g ).
It is reported that in Alzheimer's disease, oxidative stress causes DNA demethylation by decreasing the expression of DNA methyltransferases (DNMTs) possibly through the activation of c-Jun amino terminal kinase (JNK) signaling pathway. 41 To investigate the level of DNMTs in vitiligo, immunofluorescence assay was performed using the three kinds of skin specimens as previously described. Although there was no distinction in DNMT3a expression among the three groups (Supplementary Figure S10) , DNMT1 and DNMT3b were both positive in the epidermis of healthy skin but absent in lesional and perilesional epidermis (Figures 6a  and h Figure S11) . Collectively, these results suggested that ROS could reduce the expression of DNMTs by promoting the phosphorylation of JNK in melanocytes and keratinocytes.
Discussion
We found increased miR-25 in serum and lesion samples from vitiligo patients. Further experiments showed that miR-25 facilitated H 2 O 2 -induced apoptosis by impairing the antioxidant response and led to the dysfunction of melanocytes owing to its suppression on MITF. Noteworthily, miR-25 could inhibit the production and secretion of SCF and bFGF from keratinocytes and impair their paracrine protective effect on the survival of melanocytes under oxidative stress. At last, we verified that oxidative stress induced miR-25 generation in both melanocytes and keratinocytes by demethylating its promoter region. Our findings indicate that oxidative stressinduced overexpression of miR-25 has a crucial role in mediating the degeneration of melanocytes in vitiligo ( Figure 7) .
Our microarray analysis implicated the overexpression of miR-25 in vitiligo serum, which is consistent with a report by Shi et al. 42 Importantly, miR-25 was closely related with the activity of vitiligo and upregulated in the whole lesional epidermis. Although the melanocytes in lesional skin had been disappeared, we observed an intensively positive expression of miR-25 in perilesional skin that was harvested at the edge of vitiligo lesion. We speculated that this phenomenon resulted from oxidative stress in vitiligo. Further in vitro assays confirmed the inductive effect of oxidative stress on miR-25 production in both melanocytes and keratinocytes.
The destruction of melanocytes is a key event in the development of vitiligo, the underlying mechanism of which is still puzzling. Studies have confirmed melanocyte apoptosis in
vitiligo by observing nuclear shrinkage, vacuolization and detachment. 43 We proved that miR-25 could promote H 2 O 2 -induced melanocyte apoptosis by suppressing the expression of MITF, a master regulator of melanocyte survival and function. [44] [45] [46] [47] Subsequent experiments demonstrated that APE1, a transcription target of MITF important for the antioxidant response, could be inhibited by miR-25, and its re-introduction could counteract the facilitating effect of miR-25 on ROS-induced melanocyte apoptosis. We further detected the downregulation of HO-1 and GPX1, two antioxidant genes, in melanocytes overexpressing miR-25.
These findings suggested that miR-25 could suppress the antioxidant response through inhibiting MITF-APE1 pathway, thus making melanocytes more susceptible to oxidative stress-induced destruction.
As poorly functioning melanocytes have been isolated from lesional vitiligo skin and cultured in vitro, [48] [49] [50] [51] the deterioration of melanocyte function may be an early and crucial event in vitiligo. We found that miR-25 downregulated the expression of TYR, TYRP1 and TYRP2, as well as tyrosinase activity in melanocytes, thus impairing melanin synthesis. Rescue experiments further verified that the regulation depended on c) and (i, j) DNMT1 and DNMT3b mRNAs were analyzed in normal human melanocytes exposed to 400 μM H 2 O 2 , normal human keratinocytes and exposed to 1000 μM H 2 O 2 and control groups using qRT-PCR. *Po0.05. (d, e) and (k, l) DNMT1 and DNMT3b expression (each in red) was shown in normal human melanocytes exposed to 400 μM H 2 O 2 , normal human keratinocytes exposed to 1000 μM H 2 O 2 and control groups using immunofluorescence. Nuclei were counterstained with DAPI (blue). Data are representative of three biological replicates. MC, melanocyte; KC, keratinocyte. Scale bar = 50 mm. (f, g) and (m, n) The protein level of DNMT1 and DNMT3b was analyzed in normal human melanocytes exposed to 400 μM H 2 O 2 , normal human keratinocytes and exposed to 1000 μM H 2 O 2 and control groups using western blotting. Data are representative of three independently performed experiments. β-Actin was detected as loading control the suppression of MITF, which is consistent with previous findings that MITF is a transcription activator regulating those melanogenesis-related genes. [52] [53] [54] Furthermore, the process of melanosome transportation could be disturbed by miR-25. In that case, miR-25 is possibly involved in the entire pathological development of vitiligo, from the initial dysfunction to the final disappearance of melanocytes.
The homeostasis of melanocytes is influenced by a complex paracrine network consisting of growth factors secreted by keratinocytes. The deficiency of this paracrine network may cause an adverse microenvironment, which can lead to the loss of melanocytes in vitiligo. We found that miR-25 impaired the production and secretion of SCF and bFGF from keratinocytes, both of which have been reported to promote melanocyte growth and show lower expression in vitiligo lesions. 55 Consistent with previous findings, the culture medium of miR-25-knockin keratinocytes failed to conduct the protective effect on H 2 O 2 -treated melanocytes. Given the above, we believe that increased miR-25 in keratinocytes also contributes to melanocyte destruction in vitiligo.
It is reported that oxidative stress could inhibit the expression of DNMTs through JNK signaling pathway, thus inducing DNA demethylation and contributing to the development of Alzheimer's disease. 41 In our study, oxidative stress successfully caused the demethylation of CpG sites in the promoter region of miR-25, and demethylation reagent did elevate miR-25 level in melanocytes and keratinocytes. In addition, we found that H 2 O 2 reduced the expression of DNMTs by promoting JNK phosphorylation in both melanocytes and keratinocytes. It is worth mentioning that except for miR-25, decreased DNMTs may break the balance between DNA methylation and demethylation and cause aberrant expression of many other genes that may have a role in the development of vitiligo.
In conclusion, miR-25 is an important miRNA that promotes oxidative stress-induced melanocyte degeneration by not only suppressing MITF in melanocytes but also impairing the paracrine protective effect of keratinocytes. To our knowledge, this is the first study to describe the role of miRNAs in the pathogenesis of vitiligo, and our findings, to some extent, deepen the mechanism of melanocyte degeneration caused by oxidative stress in vitiligo. Further studies using appropriate animal models of vitiligo are still needed to fully clarify the pathogenic role of miR-25 in vivo and evaluate its potential to be a therapeutic target in vitiligo.
Materials and methods
Clinical assessment and patient materials. Serum samples for microarray and qRT-PCR analysis were collected from 130 patients with vitiligo and 130 healthy subjects. Skin specimens for qRT-PCR analysis were taken from the abdomen of six vitiligo patients and four healthy volunteers. Skin tissues for FISH and immunofluorescence were later taken from another three vitiligo patients and three healthy donors. The patients were diagnosed according to the criteria of the Vitiligo Area Severity Index (VASI) and the Vitiligo European Task Force (VETF). 56 All the vitiligo cases were diagnosed by clinical examination and Wood's lamp. All of the patients enrolled in our study had no other autoimmune or systemic diseases, and none of the patients received systemic treatment, including glucocorticoids, immunomodulating agents and phototherapy, within 1 month prior to the sample collection period. Segmental vitiligo was excluded from the present study. Disease stability is assessed using the combined criteria of a clinical scoring system (VASI and VETF), patient self-reporting and serial digital imaging of specific lesions over 12 months. 1 All of the patients and control subjects were pair-matched in age and gender, and informed consent was obtained from all the patients and control subjects. The research protocol was designed and executed according to the principles of the Declaration of Helsinki and was approved by the ethics review board of Fourth Military Medical University.
Microarray analysis. MiRNA microarrays were performed using Agilent's miRNA Microarray System (Agilent, Santa Clara, CA, USA) according to the manufacturer's instructions. Briefly, total RNA was isolated from serum sample using the one-step protocol of the mir Vana miRNA Isolation Kit (Ambion, Austin, TX, USA). For each sample and replicate, 100 ng of total RNA were fluorescently labeled with Cyanine 3-pCp and hybridized to oligonucleotide arrays for 20 h at 55°C. After washing the microarrays in an ozone-depleted room, the array slides were scanned and analyzed using an Agilent DNA microarray scanner. Microarray images were processed using Feature Extraction Software 9.5.3 (Agilent). Processed data were imported into Microsoft Office Excel 2010 for further analysis. The Wilcoxon Rank Sum test was used to compare the difference in serum miRNAs between vitiligo patients and healthy controls. P-values were adjusted for multiple testing using the Benjamini and Hochberg method. Only miRNAs with false discovery rateo0.01 were considered significant. MiRNAs were considered differentially regulated if at least twofold upregulation or downregulation was observed. Hierarchical clustering was performed using TIGR Multi Experiment Viewer Version 4.0. MiRNA isolation and real-time qRT-PCR. MiRNA isolation from serum and skin samples were performed using the miRNeasy Serum/Plasma Kit and Micro Kit (Qiagen, Valencia, CA, USA) following the manufacturer's protocol, respectively. MiRNeasy Serum/Plasma Spike-In Control (C. elegans miR-39) was added to serum as controls. Serum and skin cDNA were synthesized from miRNA using miRNA cDNA First Strand Synthesis and miRNA SYBR qRT-PCR Kit (Qiagen). QRT-PCR was performed with a BIO-RAD Multicolor Real-time PCR Detection System (iQTM5; Bio-Rad, Hercules, CA, USA) using primers and templates that were mixed with SYBR Premix. The primers of cel-miR-39, hsa-let-7b, hsa-miR-16, hsa-miR-451, hsa-miR-25 and hsa-miR-15b were purchased from Qiagen. DNA was amplified for 40 cycles of denaturation for 20 s at 95°C and annealed for 60 s at 60°C. Threshold cycle (CT) for each miRNA was determined using the iQ5-standard Edition Optical System ver 2.1 (Bio-Rad). Relative quantification was performed according to the ΔΔCT method, and results were expressed in the linear form using the formula 2 -ΔΔCT . Serum transcript levels of hsa-miR-25 were normalized to those of cel-miR-39, while skin transcript levels of hsa-miR-25 were normalized to those of RUNU6.
Fluorescence in situ hybridization. FISH was performed on formalinfixed paraffin-embedded sections (10 μm in thickness) of skin biopsy specimens from three vitiligo patients and three healthy individuals. After dewaxation, sections were treated with proteinase K (2 μg/ml) at 37°C for 15 min, washed and prehybridized for 30 min at 37°C. Hybridization with FAM-labeled locked nucleic acid-based probes specific for mir-25 (Exiqon, Vedbaek, Denmark) was performed overnight at 60°C. Slides were then washed at 60°C. Co-staining for melanocytes was performed by incubation with Melan-A (mouse monoclonal anti-Melan A antibody, 1 : 100, Abcam Inc., Cambridge, MA, USA) for 1 h at 36°C, followed by 1 h incubation with appropriate Alexa Fluor 640 secondary antibodies (Life Technologies, Carlsbad, CA, USA). DAPI (Dako, Glostrup, Denmark) was used as a counterstain.
Cell culture and treatment. Normal human melanocytes that were isolated from human foreskin specimens obtained during circumcision surgery were cultured in Medium 254 (Gibco, Grand Island, NY, USA) supplemented with Human Melanocyte Growth Supplement (Gibco) at 37°C in the presence of 5% CO 2 . The second-or third-passage keratinocytes were used in all experiments. Normal human keratinocytes were extracted from plastic surgery skin obtained from healthy individuals with cells cultured in the serum-free keratinocyte growth medium (Gibco). The CM of normal human keratinocytes was collected at 48 h after transfection and stored at − 80°C until use. Oxidative stress in normal human melanocytes was induced by treatment of 400 μM H 2 O 2 (Sigma, St. Louis, MO, USA) for 24 h. Oxidative stress in normal human keratinocytes was induced by treatment of 1000 μM H 2 O 2 (Sigma) for 24 h. Demethylation is induced by treatment of 5 mM 5-aza-dC (Sigma) for 24 h. JNK inhibition was induced by pretreatment on the cells for 1 h of JNKi (SP600125) (Selleck Chemicals, Houston, TX, USA) stimulation (10 mmol/l) before the H 2 O 2 treatment.
Oligonucleotide transfection into cells. Hsa-miR-25 mimics, hsamiR-25 inhibitor and negative control were double-stranded RNA oligonucleotides that were purchased from Invitrogen (Carlsbad, CA, USA). They were transfected into normal human melanocytes or normal human keratinocytes using Lipofectamine 3000 (Invitrogen) according to the manufacturer's instructions.
Detection of apoptosis. To quantify apoptotic death, normal human melanocytes were plated in six-well plates at a density of 2-3 × 10 5 cells per well overnight. At 48 h after transfection, the cells were directly collected or switched into serum-free, antibiotic-free DMEM (with or without the mixture of keratinocyte CM with an 1 : 1 ratio) and exposed to 400 μM H 2 O 2 (Sigma) for 24 h before collection. Apoptotic cells were identified using the Annexin V-PE Apoptosis Detection Kit (MaiBio, Shanghai, China) following the manufacturer's instructions. The number of apoptotic cells was quantified by flow cytometry (Beckman Coulter, Miami, FL, USA), and the analysis was carried out using the Expo32 software (Beckman Coulter). Each sample was repeated in triplicate.
Western blotting. After treatment, cells were washed two times with ice-cold phosphate-buffered saline (PBS) and then lysed with cell lysis solution (DSL, Webster, TX, USA). Proteins were extracted from cells and quantified using BCA Protein Assay kit (Pierce, Rockford, IL, USA). Equal amounts of protein were separated by 10% SDS-PAGE (Bio-Rad) and were then transferred from the gel to polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA). Page Ruler Plus Prestained Protein Ladder (Fermentas, Hanover, MD, USA) was used to confirm protein electrophoresis and transferring. After blocking in a solution of 5% non-fat dry milk diluted in Tris-buffered saline, the membranes were washed and then incubated with primary antibodies (rabbit polyclonal anti-MITF, 1 : 1000, Abcam; rabbit monoclonal anti-Bcl-2, 1 : 500, Abcam; rabbit monoclonal to Bax, 1 : 2000, Abcam; rabbit monoclonal anti-Cleaved Caspase-3,1 : 1000, Cell Signaling Technology (Danvers, MA, USA); rabbit polyclonal anti-Cleaved Caspase-9,1 : 1000, Cell Signaling Technology; mouse monoclonal to Tyrosinase, 1 : 250, Abcam; rabbit monoclonal to TYRP1, 1 : 10000, Abcam; rabbit polyclonal anti-TYRP2, 1 : 500, Abcam; mouse monoclonal anti-APE1, 1 : 2000, Abcam; rabbit monoclonal anti-SCF, 1 : 10000, Abcam; mouse monoclonal anti-Endothelin 1, 1 : 500, Abcam; rabbit monoclonal anti-bFGF, 1 : 1000, Cell Signaling Technology; rabbit polyclonal anti-CXCL10, 1 : 1000, Abcam; rabbit polyclonal anti-CXCL9, 1 : 5000, Abcam; rabbit polyclonal anti-DNMT1 antibody, 1 : 1000, Abcam; rabbit polyclonal antiDNMT3b, 1 : 500, Abcam; rabbit monoclonal anti-Bax, 1 : 2000, Abcam; rabbit monoclonal anti-phospho-JNK, 1 : 1000, Cell Signaling Technology; rabbit monoclonal anti-β-actin, 1 : 5000, Abcam) overnight at 4°C. After being washed, the membranes were incubated with horseradish peroxidase-conjugated secondary antibodies (Goat Anti-Mouse IgG, 1 : 5000; Goat Anti-Rabbit IgG, 1 : 10000) for 2 h at room temperature. Bound antibodies were detected using the ECL western blotting detection system (Millipore).
5-Ethynyl-2′-deoxyuridine assay. Forty-eight hours after transfection, EdU (Cell Light EdU DNA imaging Kit, RiboBio, Guangzhou, China) was added at a 10 mM final concentration to the transfected cells 24 h before harvesting. The cells were then stained according to the following protocol: discard the EdU medium mixture, add 4% paraformaldehyde to fix cells at room temperature for 30 min, wash with glycine (2 mg/ml) for 5 min in a shaker, add 0.2% Triton X-100 for 10 min, wash with PBS for two times, add click reaction buffer (Tris-HCl, pH 8.5, 100 mM; CuSO4, 1 mM; Apollo 550 fluorescent azide, 100 mM; ascorbic acid, 100 mM) for 30 min while protecting from light, wash with 0.5% Triton X-100 for three times, stain with Hoechst (5 mg/ml) for 30 min at room temperature, wash with 0.5% Triton X-100 for five times and, finally, add 150 ml PBS. Images were taken and analyzed using High Content Imaging Pathway 855 (BD, Franklin Lakes, NJ, USA). EdU-positive cells were calculated by (EdU add-in cells/Hoechst stained cells) × 100%.
Tyrosinase activity and measurement of melanin content. Tyrosinase activity was determined as described by Tomita et al. 57 with slight modification. Normal human melanocytes were plated at a density of 2.5 × 10 3 cells/ well in 96-well plates. After incubation with test substances for 48 h, cells were washed with ice-cold PBS and lysed with phosphate buffer (pH 6.8) containing 1% Triton-X/PBS (90 μl/well) and then frozen at − 80°C for 30 min. After thawing and mixing, 10 μl of 1% L-DOPA was added to each well. Following incubation at 37°C for 2 h, the absorbance was measured at 492 nm using an ELISA reader (Thermo Fisher Scientific Inc., Waltham, MA USA). Melanin content was measured according to the method of Tsuboi et al. 58 with slight modifications. Briefly, cells were treated with test substances for 2 days, and cell pellets containing a known number of cells (5 × 10 5 ) were dissolved in 0.5 ml of 1 M NaOH at 100°C for 30 min and centrifuged for 20 min at 16 000 × g. Optical densities of supernatants were measured at 410 nm using an ELISA reader (Thermo Fisher Scientific Inc.).
Detection of melanosome transport. Immunocytochemistry was used to detect the melanosome transport. Normal human melanocytes were cultured on glass coverslips and accepted transfection. Forty-eight hours later, sections were washed and fixed in 4% paraformaldehyde for 10 min. Subsequently, the sections were incubated with 0.5% BSA for 30 min. To detect the melanosome marker gp100, cells were incubated with a polyclonal mouse anti-human gp100 antibody (1 : 200, Abcam) overnight at 4°C. After that, the cells were incubated for 1 h with a rabbit anti-mouse secondary antibody (Dako). Next, DAPI was used at a 1 : 1000 dilution for detection of cell nuclei, and coverslips were mounted using glycerol (Dako).
Enzyme-linked immunosorbent assay. CXCL9, CXCL10, ET-1, SCF and bFGF were assayed using the commercially available assay kits (Westang Biotechnology, Shanghai, China) according to the manufacturer's instructions. The absorbance (A450) was measured with a plate reader (MRP-2100, Syntron, Carlsbad, CA, USA). Detection sensitivity of this ELISA system was at least 15 pg/ ml. All samples were diluted to 1 : 50 before the assay.
Bioinformatics analysis for target genes of miRNAs. Multiple target gene prediction software, including miRanda (http://www.mocrorna.org), TargetScan (http://www.targetscan.org) and PicTar (http://pictar.mdc-berlin.de/) were used to predict potential targets of miR-25.
RNA isolation and qRT-PCR. Total RNA was isolated using Trizol reagent (Invitrogen), and then reverse-transcribed to single-strand cDNA using reverse transcription reagents according to the manufacturer's instructions. QRT-PCR experiments were performed using the IQ SYBR Green Supermix (Bio-Rad) and BIO-RAD MJ Mini Opticon Real-Time PCR System. The resulting amplification and melt curves were analyzed to ensure the identity of the specific PCR product. Threshold cycle values were used to calculate the fold change in the transcript levels by using the 2 -ΔΔCT method. The relative mRNA expression levels were normalized to the actin gene. The primer sequences are listed in Supplementary  Table S2 . Luciferase reporter assay. Transfections of melanocytes were performed using Lipofectamine 3000 (Invitrogen) according to the manufacturer's recommendations. All transfections were performed in triplicate. Luciferase vectors (100 ng) (MITF WT, MITF MUT, SCF WT, SCF MUT, bFGF WT, bFGF MUT and the empty vectors) were individually transfected into normal human melanocytes or normal human keratinocytes along with 100 nM hsa-miR-25 mimics (Invitrogen) or 100 nM negative control (Invitrogen). Forty-eight hours after transfection, luciferase assays were performed using the Dual-Luciferase Reporter Assay System (Promega Corporation). For each transfection, the luciferase activity of three replicates was averaged.
Plasmid construction and transfection for rescue experiments. Human 3′UTR-deleted MITF mRNA and Human APE1 mRNA was amplified by RT-PCR and cloned into the GV141 vector (Genechem, Shanghai, China) between the EcoRI and BamHI restriction sites, respectively. The vectors were sequenced to confirm the insert direction and sequences.
DNA methylation analysis. Genomic DNA was extracted from the cultured cells by using Wizard HSV Genomic DNA Purification System (Promega Corporation) according to the manufacturer's instructions. The integrity and purity of DNA were spectrophotometrically examined according to its A260/A280 absorption. A total of 200 ng genomic DNA from each sample was bisulfitetreated with the Methylamp DNA Modification Kit (Epigentek, Brooklyn, NY, USA). The quality of bisulfite conversion was evaluated using the PCR products without methyl groups as the control. Sequenom Mass ARRAY platform (CapitalBio, Beijing, China), which was composed of matrix-assisted laser desorption/ionization time-offlight mass spectrometry and combined with RNA base-specific cleavage was used to analyze miR-25 methylation quantitatively (Gen-Bank Accession Number: NM_053304.1). PCR primers were designed using Methprimer (http://www.urogene. org/methprimer/). For each reverse primer, an additional T7 promoter tag for in vivo transcription was added, whereas a 10-m tag on the forward primer was used to adjust melting temperature differences. Supplementary Table S3 lists all the primers used in this study. The methylation ratios were generated by Epityper software version 1.0 (Sequenom, San Diego, CA, USA). The generated data were put into the EPI 3.1 Database (EpiData Association, Odense, Denmark) and analyzed with SPSS 11.5 software (SPSS Inc, Chicago, IL, USA). Independent t-tests were conducted to evaluate the difference between the experimental and control groups. Po0.05 was considered statistically significant.
Immunofluorescence. Paraffin-embedded tissue sections were deparaffinized and rehydrated with graded ethanol dilutions. After antigen retrieval in sodium citrate buffer (10 mM, pH 6.0), immunofluorescence staining was performed by incubating the paraffin sections with a primary antibody (rabbit polyclonal anti-DNMT1 antibody, 1 : 1000, Abcam; rabbit polyclonal anti-DNMT3a antibody, 1 : 50, Abcam; rabbit polyclonal anti-DNMT3b antibody, 1 : 50, Abcam). Co-staining for melanocytes was performed by incubation with Melan-A (mouse monoclonal antiMelan A antibody, 1 : 100, Abcam) overnight at 4°C, followed by 1 h incubation with appropriate secondary antibodies (goat anti-rabbit Alexa Fluor 640 Dye 1 : 5000 and goat anti-mouse Alexa Fluor 488 Dye, 1 : 5000, Life Technologies). DAPI (Dako) was used as a counterstain. Tissue sections were analyzed by confocal laser scanning microscopy (LSM510; Carl Zeiss AB, Jena, Germany).
Melanocytes and keratinocytes for immunofluorescence staining were first seeded on coverslips in a 24-well plate and allowed to adhere before staining. Cells were washed with PBS, fixed with 4% paraformaldehyde for 10-20 min, and permeabilized with 10% saponin for 5 min followed by acetone treatment at − 20°C for 10 min. After washing the slides with PBS, cells were blocked with normal goat sera at room temperature for 1 h. Cells were incubated with primary antibody diluted in the blocking solution at 4°C overnight. The primary antibodies were as follows: rabbit polyclonal anti-DNMT1 antibody, 1 : 1000 (Abcam); rabbit polyclonal anti-DNMT3b antibody, 1 : 50 (Abcam). Cells were washed with PBS and incubated with secondary antibodies (goat anti-rabbit Alexa Fluor 640 Dye, 1 : 5000, Life Technologies) at room temperature for 1 h. Nuclei were stained with DAPI (Dako) and subsequently analyzed by confocal laser scanning microscopy (LSM 510).
Statistical analysis. Each experiment was performed at least for three times, and statistical analyses of the data were performed using unpaired, two-tailed Student's t-tests built into GraphPad Prism (GraphPad Software 3.0; San Diego, CA, USA). All the data are expressed as the mean ± S.D. P-values ofo0.05 were considered statistically significant.
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